We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Vitamins D, E, B and T

1 February 2017 By Jeffrey Goldfarb

The buyout firm is shopping nutritional-supplements maker Nature’s Bounty for up to $6 bln. That price would deliver a 20 pct IRR for what was a pivotal deal in 2010. Carlyle’s timing and strategic nous may have led to a higher valuation. Debt, however, provided the real muscle.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)